Open Philanthropy recommended an investment of $5,000,000 in Alvea to support the creation of a platform for developing and deploying medicines for pandemic preparedness.
This falls within Open Philanthropy’s focus area of global catastrophic risks, specifically within its interest in biosecurity and pandemic preparedness.